WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997035571) BENZOTHIOPHENES, FORMULATIONS CONTAINING SAME, AND METHODS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/035571    International Application No.:    PCT/US1997/004259
Publication Date: 02.10.1997 International Filing Date: 20.03.1997
Chapter 2 Demand Filed:    01.08.1997    
IPC:
C07D 333/56 (2006.01)
Applicants: ELI LILLY AND COMPANY [US/US]; Lilly Corporate Center, Indianapolis, IN 46285 (US) (For All Designated States Except US).
ARBUTHNOT, Gordon, N. [US/US]; (US) (For US Only).
DALDER, Brian, W. [US/US]; (US) (For US Only).
HARTAUER, Kerry, J. [US/US]; (US) (For US Only).
LUKE, Wayne, D. [US/US]; (US) (For US Only).
STRATFORD, Robert, E., Jr. [US/US]; (US) (For US Only)
Inventors: ARBUTHNOT, Gordon, N.; (US).
DALDER, Brian, W.; (US).
HARTAUER, Kerry, J.; (US).
LUKE, Wayne, D.; (US).
STRATFORD, Robert, E., Jr.; (US)
Agent: SALES, James, J.; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285 (US)
Priority Data:
60/014,167 26.03.1996 US
9607110.5 04.04.1996 GB
Title (EN) BENZOTHIOPHENES, FORMULATIONS CONTAINING SAME, AND METHODS
(FR) BENZOTHIOFENES, FORMULATIONS DANS LESQUELLES ILS ENTRENT ET TECHNIQUES
Abstract: front page image
(EN)This invention provides compounds of formula (I) and pharmaceutically acceptable salts an solvates thereof, characterized that the compound is in particulate form and has a specific size range. The present invention further provides pharmaceutical compositions containing or formulated using compounds of formula (I), and the use of such compounds for alleviating human pathologies, including osteoporosis, serum lipid lowering, and breast cancer.
(FR)Composés de formule (I) et sels et solvats de ceux-ci, acceptables sur le plan pharmaceutique, caractérisés par le fait que le composé se présente sous forme particulaire et possède une fourchette granulométrique spécifique. L'invention porte aussi sur des compositions pharmaceutiques comprenant des composés de la formule (I) ou formulées selon ceux-ci, et sur l'emploi de tels composés pour soulager des pathologies humaines, dont l'ostéoporose, la baisse des lipides sériques et le cancer du sein.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, HU, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU.
African Regional Intellectual Property Organization (GH, KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)